D. Cruickshank

发表

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

D. Oram, M. Parmar, I. Jacobs, 2016, The Lancet.

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Matthew Burnell, Steven J Skates, Tim Mould, 2009, Journal of Family Planning and Reproductive Health Care.

The clinical significance of pre‐operative serum CA 125 in ovarian cancer

D. Cruickshank, W. Fullerton, A. Klopper, 1988, British journal of obstetrics and gynaecology.

Acute changes in iron metabolism following myocardial infarction.

D. Cruickshank, D. Campbell, J. Matthews, 1985, American journal of clinical pathology.

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

D. Cruickshank, S. M. Crawford, S. Kaye, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recruitment to multicentre trials lessons from

Lesley, Leeson, M. Parmar, 2008 .

UKCTOCS: descriptive study Recruitment to multicentre trialslessons from

M. Parmar, I. Jacobs, U. Menon, 2008 .

Linkage studies with 17q and 18q markers in a breast/ovarian cancer family.

H. Kitchener, D. Cruickshank, N. Haites, 1993, American journal of human genetics.

Management of Early Cervical Stromal Invasion FIGO Stage 1A1 When Margins Are Involved With Cervical Intraepithelial Neoplasia

D. Cruickshank, G. Angelopoulos, J. Twigg, 2018, Journal of lower genital tract disease.

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

G. Jayson, D. Cruickshank, P. Wilkinson, 2005, British Journal of Cancer.

The role of routine follow‐up after gynecological malignancy

D. Cruickshank, F. Kew, A. Roberts, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Preconceptions versus experience of transvaginal ultrasonography in older women

D. Cruickshank, V. Whittaker, F. Kew, 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Tolerability of Transvaginal Ultrasonography as an Ovarian Cancer Screening Test

D. Cruickshank, V. Ashton, F. Kew, 2004 .

CA125‐response assessment in epithelial ovarian cancer

D. Cruickshank, W. Fullerton, P. Terry, 1992, International journal of cancer.

The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancer.

D. Cruickshank, W. Fullerton, P. Terry, 1991, The International journal of biological markers.

Primary carcinoid tumours of the ovary

D. Cruickshank, D. Cruickshank, J. Davies-Humphreys, 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Providing a quality service: direct referral from the cytology laboratory to the colposcopy clinic

D. Cruickshank, V. Whittaker, F. Kew, 2005, Journal of medical screening.

Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole

D. Cruickshank, B. Bennett, N. Booth, 1993 .

Routine follow-up after treatment for a gynecological cancer: a survey of practice

D. Cruickshank, F. Kew, 2004, International Journal of Gynecologic Cancer.

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.

D. Cruickshank, S. Kaye, S. Kaye, 1992, British Journal of Cancer.

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

D. Cruickshank, S. M. Crawford, S. Kaye, 1992, The Lancet.

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

H. Putter, B. Monk, D. Provencher, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Routine follow-up after treatment for a gynecological cancer: a survey of practice.

D. Cruickshank, F. Kew, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The role of routine follow-up after gynecological malignancy

D. Cruickshank, F. Kew, A. Roberts, 2004, International Journal of Gynecologic Cancer.

The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients

D. Cruickshank, P. V. van Dam, W. Tjalma, 2004, International Journal of Gynecologic Cancer.

Caesarean section audit by peer review.

D. Cruickshank, C. Bain, V. Wareham, 1993, European journal of obstetrics, gynecology, and reproductive biology.

Screening for uterine neoplasms

H. Kitchener, D. Cruickshank, 1990, The Lancet.

FIGO stage 1a1 squamous cell carcinoma arising in a traumatic uterovaginal fistula

D. Cruickshank, G. Raje, 2006, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Independent expression in serum of three tumor‐associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma

D. Cruickshank, S. Love, B. Ward, 1988, British journal of obstetrics and gynaecology.

Pseudomembranous colitis as a complication of cisplatin andcyclophosphamide: a case report and review

D. Cruickshank, K. Lincoln, C. Ritchie, 1997 .

Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study.

D. Cruickshank, D. Campbell, I. Macgillivray, 1992, European journal of obstetrics, gynecology, and reproductive biology.

Intra-uterine growth retardation and maternal labetatol treatment in a random allocation controlled study

D. Cruickshank, D. Campbell, I. Macgillivray, 1992 .

Maternal Obstetric Outcome Measures in A Randomised Controlled Study of Labetalol in the Treatment of Hypertension in Pregnancy

D. Cruickshank, D. Campbell, I. Macgillivray, 1991 .

Atenolol in essential hypertension during pregnancy.

D. Cruickshank, D. Campbell, 1990, BMJ.

Chemotherapy in advanced ovarian cancer.

D. Cruickshank, 1991, BMJ.

Aetiological importance of ovulation in epithelial ovarian cancer: a population based study.

D. Cruickshank, Derek J Cruickshank, 1990, BMJ.

Circulating tumour‐associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer

D. Cruickshank, B. Ward, 1987 .

The clinical significance of pre‐operative serum CA 125 in ovarian cancer

D. Cruickshank, W. Fullerton, A. Klopper, 1987, British journal of obstetrics and gynaecology.

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Matthew Burnell, Martin Widschwendter, Tim Mould, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice.

J. Ledermann, D. Cruickshank, H. Gabra, 2017, European journal of obstetrics, gynecology, and reproductive biology.

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer

D. Cruickshank, C. Redman, D. Parker, 1992, International Journal of Gynecologic Cancer.

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

Matthew Burnell, Steven J Skates, Tim Mould, 2011, The Lancet. Oncology.

P420 A randomised controlled trial of oral versus vaginal misoprostol for medical management of early fetal demise

D. Cruickshank, J. Anderson, A. Elattar, 2009 .

Medical termination of pregnancy at 63 to 83 days gestation

D. Cruickshank, K. Lincoln, E. Gouk, 1999, British journal of obstetrics and gynaecology.

VAGINAL ENDOSONOGRAPHY IN ENDOMETRIAL CANCER

D. Cruickshank, I. Miller, J. Randall, 1989, The Lancet.

The multidisciplinary management of a family with epithelial ovarian cancer

D. Cruickshank, N. Haites, O. Eremin, 1992, British journal of obstetrics and gynaecology.

Cervical Cancer Screening in Developing Countries

D. Cruickshank, Derek J. Cruickshank, 2005 .

Successful treatment of vulval melanoma in situ with topical 5% imiquimod cream

D. Cruickshank, A. Lonsdale-Eccles, S. Nagarajan, 2006, The British journal of dermatology.

The level of haemoglobin in anaemic cancer patients correlates positively with quality of life

D. Cruickshank, H. Doll, C. Jenkinson, 2002, British Journal of Cancer.

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, I. Jacobs, U. Menon, 2008, BMJ : British Medical Journal.

Risk of epithelial ovarian cancer in asymptomatic women with ultrasound‐detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)

D. Oram, I. Jacobs, M. Parmar, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

M. Parmar, I. Jacobs, U. Menon, 2011, Trials.

Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II

D. Provencher, D. Cruickshank, M. Widschwendter, 2019, International Journal of Gynecological Cancer.

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2017, British Journal of Cancer.

Transabdominal ultrasound screening for early ovarian cancer

D. Cruickshank, 1990 .

Standardising Our Management Of Postcoital Bleeding

D. Cruickshank, V. Bamigboye, A. Khattab, 2006 .

An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer.

D. Cruickshank, S. Kaye, J. Paul, 1992, British Journal of Cancer.